News coverage about Metlife (NYSE:MET) has been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Metlife earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 47.952945717076 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the headlines that may have effected Accern Sentiment’s analysis:

A number of brokerages recently commented on MET. Zacks Investment Research lowered shares of Metlife from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. Deutsche Bank began coverage on shares of Metlife in a research note on Tuesday, January 2nd. They issued a “hold” rating and a $55.00 price target on the stock. Wells Fargo & Co set a $62.00 price target on shares of Metlife and gave the company a “buy” rating in a research note on Thursday, December 14th. Sandler O’Neill lowered shares of Metlife from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. Finally, ValuEngine lowered shares of Metlife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 9th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $57.90.

Shares of Metlife (NYSE MET) traded down $0.16 during trading hours on Monday, hitting $53.33. 5,480,396 shares of the company’s stock were exchanged, compared to its average volume of 4,464,745. Metlife has a 1 year low of $44.26 and a 1 year high of $55.91. The firm has a market cap of $56,120.00, a price-to-earnings ratio of 115.93, a PEG ratio of 1.20 and a beta of 1.49. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16.

Metlife (NYSE:MET) last announced its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.19. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The firm had revenue of $16.10 billion for the quarter, compared to analyst estimates of $15.47 billion. During the same quarter in the prior year, the business posted $1.28 EPS. The business’s revenue was up 1.7% compared to the same quarter last year. analysts forecast that Metlife will post 4.4 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.00%. Metlife’s payout ratio is presently 347.83%.

In other news, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the completion of the sale, the insider now owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the sale, the insider now directly owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/metlife-met-receives-media-sentiment-score-of-0-11/1808386.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Insider Buying and Selling by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.